Table 1 PVT-1 expression and clinicopathological factors in 164 colorectal cancer cases
From: Amplification of PVT-1 is involved in poor prognosis via apoptosis inhibition in colorectal cancers
Low expression | High expression | |||||
|---|---|---|---|---|---|---|
n=33 | n=131 | |||||
Factors | Number | % | Number | % | P -value | |
Age (y) | <65 | 10 | 30.30% | 48 | 36.64% | 0.4922 |
>66 | 23 | 69.70% | 83 | 63.36% | ||
Sex | Male | 19 | 57.58% | 78 | 59.54% | 0.8375 |
Female | 14 | 42.42% | 53 | 40.46% | ||
Histological grade | Well/moderate | 31 | 93.94% | 121 | 92.37% | 0.7514 |
other | 2 | 6.06% | 10 | 7.63% | ||
Tumour size | <30 mm | 7 | 21.21% | 33 | 25.19% | 0.6303 |
⩾30 mm | 26 | 78.79% | 98 | 74.81% | ||
Serosal invasion | Absent | 12 | 36.36% | 36 | 27.48% | 0.3236 |
Present | 21 | 63.64% | 95 | 72.52% | ||
Lymph node metastasis | N0 | 24 | 72.73% | 62 | 47.33% | 0.0079a |
N1-2 | 9 | 27.27% | 69 | 52.67% | ||
Lymphatic invasion | Absent | 24 | 72.73% | 73 | 55.73% | 0.0702 |
Present | 9 | 27.27% | 58 | 44.27% | ||
Venous invasion | Absent | 30 | 90.91% | 100 | 76.34% | 0.0472a |
Present | 3 | 9.09% | 31 | 23.66% | ||
Liver metastasis | Absent | 32 | 96.97% | 114 | 87.02% | 0.0649 |
Present | 1 | 3.03% | 17 | 12.98% | ||
Peritoneal dissemination | Absent | 33 | 100.00% | 123 | 93.89% | 0.0545 |
Present | 0 | 0.00% | 8 | 6.11% | ||
Distant metastasis | Absent | 32 | 96.97% | 128 | 97.71% | 0.8104 |
Present | 1 | 3.03% | 3 | 2.29% | ||
UICC Stage | 0, I, II | 24 | 72.73% | 57 | 43.51% | 0.0023a |
III, IV | 9 | 27.27% | 74 | 56.49% | ||
